WHEN IT COMES TO THE TREATMENT
OF INFANTILE SPASMS

Time to treatment initiation
and effective dosing can
have a significant and
lasting impact

Pyros Pharmaceuticals is developing enhanced specialty pharmaceuticals for rare diseases

Join Us

At upcoming conferences

View

What's in our pipeline

Meet

Our outstanding people

Explore

Career opportunities at Pyros

At Pyros, we're focused on setting a new standard in healthcare, starting with patients suffering from infantile spasms. We're taking this opportunity to lift up families and support them in treating this severe, rare disease.

Michael Smith

Chief Executive Officer